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Abstract
Compound A possesses glucocorticoid receptor (GR)-dependent anti-inflammatory properties. Just like classical GR ligands,
Compound A can repress NF-kB-mediated gene expression. However, the monomeric Compound A-activated GR is unable
to trigger glucocorticoid response element-regulated gene expression. The heat shock response potently activates heat
shock factor 1 (HSF1), upregulates Hsp70, a known GR chaperone, and also modulates various aspects of inflammation. We
found that the selective GR modulator Compound A and heat shock trigger similar cellular effects in A549 lung epithelial
cells. With regard to their anti-inflammatory mechanism, heat shock and Compound A are both able to reduce TNF-
stimulated IkBa degradation and NF-kB p65 nuclear translocation. We established an interaction between Compound A-
activated GR and Hsp70, but remarkably, although the presence of the Hsp70 chaperone as such appears pivotal for the
Compound A-mediated inflammatory gene repression, subsequent novel Hsp70 protein synthesis is uncoupled from an
observed CpdA-induced Hsp70 mRNA upregulation and hence obsolete in mediating CpdA’s anti-inflammatory effect. The
lack of a Compound A-induced increase in Hsp70 protein levels in A549 cells is not mediated by a rapid proteasomal
degradation of Hsp70 or by a Compound A-induced general block on translation. Similar to heat shock, Compound A can
upregulate transcription of Hsp70 genes in various cell lines and BALB/c mice. Interestingly, whereas Compound A-
dependent Hsp70 promoter activation is GR-dependent but HSF1-independent, heat shock-induced Hsp70 expression
alternatively occurs in a GR-independent and HSF1-dependent manner in A549 lung epithelial cells.
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Introduction
Inflammation is a complex immune response of tissues to
harmful stimuli, such as the self-produced tumor necrosis factor
(TNF) characterized by an activator protein-1 (AP-1) and/or
nuclear factor kB (NF-kB)-mediated generation of cytokines and
chemokines, e.g. IL6 and IL8. In unstimulated cells, NF-kB is
restrained in the cytoplasm by the NF-kB-binding inhibitory
protein IkB. Upon induction, the IkB kinase (IKK) complex,
comprising two catalytic components, IKKa and IKKb, and a
regulatory component IKKc (NEMO), can phosphorylate IkB,
destining this inhibitory factor for ubiquitination and subsequent
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degradation by the 26S proteasome. Ensuing, the freed and
activated NF-kB p65-p50 heterodimer translocates into the
nucleus, where it will bind onto specific promoter recognition
sites and activate multiple pro-inflammatory genes [1].
Glucocorticoids (GCs), the steroidal ligands of the glucocorti-
coid receptor (GR, NR3C1), are efficaciously used as anti-
inflammatory drugs. Structurally, the GR comprises a N-terminal
domain in which a transactivation function is encoded, a DNA-
binding domain which also functions in GR dimerization, and a
C-terminal ligand-binding domain which harbors a second
transactivation function [2]. The unactivated GR resides predom-
inantly in the cytoplasm where a chaperone complex consisting of
heat shock protein 70 (Hsp70), Hsp90 and variable immunophilins
keeps the receptor in a ligand-receptive state [3]. After GCs bind
to the GR, the receptor’s conformation changes and as a result GR
sheds its chaperone complex and translocates into the nucleus,
where it can activate or repress specific gene transcription [2]. The
GC-activated GR can positively affect gene expression via
dimerized GR binding onto specific GC-responsive elements
(GREs) in the promoter. Conversely, GC-activated GR can
negatively interfere with gene expression via diverse mechanisms
among which the binding of GR to a negative GRE, tethering of
monomer GR to transcription factors such as NF-kB, and the
alteration of the composition of the transcription-initiating
enhanceosome [2]. However, long-term therapy with GCs is
burdened with a detrimental side-effect profile [4] driving ongoing
research to develop new therapeutic strategies to combat
inflammation. With this aim, we investigate Compound A (CpdA),
a phenyl aziridine precursor molecule established as a selective
GR modulator. CpdA is able to alter GR’s conformation and
drives it into the nucleus [5]. However, unlike classical GCs [6],
CpdA does not stimulate GR Ser211 phosphorylation [5] or GR
dimerization [7]. Hence, CpdA-modulated GR does not transac-
tivate GRE-regulated gene expression and safeguards the system
from various classic GC-associated side effects [5]. This selective
GR modulator is, however, a potent repressor of NF-kB-driven
pro-inflammatory gene expression, both in vitro and in vivo [8].
Mechanistically, CpdA-activated GR diminishes the TNF-stimu-
lated NF-kB transactivation capacity and DNA binding [5]. As
most GC therapy-associated side effects are linked to GR
transactivation mechanisms [9], a selective GR modulator possibly
holds great promise in future therapeutics combating inflamma-
tion.
Various stressors, including heat and proteotoxic stress, instigate
the heat shock response [10,11]. This reaction functions to protect
the cell and is characterized by the activation of the transcription
factor heat shock factor 1 (HSF1) followed by the elevated gene
expression of inducible heat shock proteins (Hsps), such as Hsp70
[11]. The heat shock-activated mechanism to stimulate Hsp70
promoter activity occurs via the activation of the transcription
factor HSF1. In a resting state, HSF1 is distributed throughout the
cell as a monomer. Upon activation, HSF1 becomes hyperpho-
sphorylated, trimerizes and aggregates in nuclear stress granules
[12,13]. The activated HSF1 oligomers can bind onto a specific
heat shock response element (HSE) to activate gene transcription
of various inducible Hsps [14,15].
Physiologically, Hsp70 can play a role as a chaperoning
molecule, ensuring proper folding and refolding of various
proteins. As such, Hsp70 contributes to keep the unactivated
GR in a ligand-receptive state [3]. The presence of Hsp70 has also
been shown to be crucial for mice to resist TNF-induced lethality
[16]. Moreover, elevated intracellular Hsp70 and activated HSF1
have been described to have anti-inflammatory abilities via
disruption of the IKK complex, abrogation of IkBa degradation
and consecutive NF-kB p65 translocation [17,18].
In brief, we report here on the modulation of Hsp70 promoter
activity via different stimuli. Interestingly, the SGRM CpdA
upregulates Hsp70 mRNA via a GR-dependent and HSF1-
independent mechanism. Although, CpdA, similar to heat shock,
hampers TNF-stimulated IkBa degradation and NF-kB p65
nuclear translocation, its anti-inflammatory mechanism does not
seem to require absolute de novo protein synthesis. Nonetheless,
the presence of adequate levels of the Hsp70 chaperone is
absolutely necessary to allow CpdA to repress NF-kB-driven gene
expression.
Materials and Methods
Cell Culture & Reagents
A549 adenocarcinoma human alveolar basal epithelial cells
were a kind gift from Dr. Ian Adcock [19]. PC-3 prostate
adenocarcinoma cells were a kind gift from Dr. Schalken and Dr.
Giroldi (Nijmegen, The Netherlands) [20]. HEK293T cells
(ATCCH CRL-11268TM), L929sA murine fibrosarcoma cells
[21] and other cells were cultured in DMEM with 10% fetal calf
serum, 100U/ml penicillin and 0.1mg/ml streptomycin. All cell
lines were grown at 37uC under 5% CO2.
Recombinant TNFa production and purification to 99%
homogeneity has been described previously [22]. Dexamethasone
(DEX) and cycloheximide (CHX) were obtained from Sigma-
Aldrich. CpdA was produced and stored as described [5]. TNFa
was used at a final concentration of 2000IU/ml and dissolved in
medium. DEX and CpdA were dissolved in ethanol and used,
respectively, at a 1mM and 10mM final concentration, unless stated
otherwise in the figure legend. Cycloheximide (CHX) was
dissolved in DMSO and used in a final concentration of 20mg/ml.
Animals and Ethics Statement
BALB/c mice were obtained from Charles River. The animal
experiment was performed in accordance with all Belgian legal
and ethical requirements and approved by the local ethics
committee of Ghent University (Permit number: 07–012). In
order to minimize suffering, intraperitoneal injections were
performed with 26G needles and mice were sacrificed by cervical
dislocation under Ketamin/Xylazin anaesthesia.
Plasmids
The plasmid p(IL6kB)350hu.IL6P-luc+ and p(GRE)250-
hu.IL6P-luc+ were described previously [23,24]. The p(GRE)250-
hu.IL6P-luc+ plasmid was derived from the p(IL6kB)350hu.IL6P-
luc+ by replacing the kB motifs with two consensus GRE sites.
The heat-inducible mHsp70i-luc reporter gene construct was
kindly donated to us by Dr. H Moo Kwon (Baltimore, Maryland)
[25].
Bait, prey and Reporter Constructs
All constructs used in this report were generated by standard
PCR- or restriction based cloning procedures. The pCLG-GR
plasmid was generated by amplifying the human GR-coding
sequence of a hGR-containing expression plasmid using primers
GGGGAGCTCCGACTCCAAAGAATCATTAAC and
GGGGCGGCCGCTCACTTTTGATGAAACAGAA, cutting
the amplicon with SacI and NotI restriction enzymes and ligating
the resulting fragment into SacI-NotI digested pCLG backbone
[26]. The pMG1 plasmid encoding an unfused gp130 receptor
fragment as an empty prey control was obtained by opening the
pMG1 vector [27] using EcoRI and XhoI, blunting the vector
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backbone through Pfu DNA Polymerase and self-ligation. The
prey plasmids pMG1-HSP90AA1 and pMG1-HSP70 were
created by Gateway transfer of the full size HSP90AA1 and
HSP70 ORFs, obtained as entry clones from the hORFeome
collection [28] into the Gateway compatible pMG1 prey
destination vector as described earlier [29]. The pXP2d2-rPAP1-
luciferase reporter has been described elsewhere [30,31].
Transfection & Reporter Gene Assays
Stable transfection of mHsp70i-luc into L929sA cells was
performed by the calcium phosphate precipitation protocol as
described [23]. Transient transfections of p(IL6kB)350hu.IL6P-
luc+ or p(GRE)250hu.IL6P-luc+ in A549 cells were performed via
lipofectamine (Invitrogen)-based procedures, as described [32].
Post-inductions, cells were washed with PBS and lysed (TROPIX).
Total solvent concentration was kept similar in all conditions.
Reporter gene expression was corrected by normalization to the
co-expressed b-galactosidase (b-gal) protein levels, as assayed via a
Galacto-Light kit (TROPIX).
For the MAPPIT analysis, HEK293T cells were cultured in a
8% CO2 humidified atmosphere at 37uC and grown in DMEM
with 10% fetal calf serum (GibcoH). 10 000 cells were seeded in
black 96-well plates. One day later, the cells were transiently co-
transfected with either a DHFR-bait plasmid (irrelevant bait, as a
negative control) or a GRa-bait plasmid, together with the
STAT3-responsive rPAP1-luci reporter plasmid and the desired
prey-plasmid. The empty prey was used as a negative control.
Twenty-four hours after transfection cells were stimulated with
leptin (100ng/ml) or leptin in combination with DEX (1mM) or
CpdA (10mM) for another 24h or were left untreated (NS). All
inductions were performed at least in triplicate. Total cell lysates
were assayed for promoter activity of the relative reporter genes
via a luciferase assay, performed according to manufacturer’s
instructions (Promega). Luciferase activity was measured by
chemiluminescence in a TopCount NXT luminometer (Perkin
Elmer).
RT-(q)PCR
For inductions, total solvent concentration was kept similar in
all conditions. Total RNA was isolated using TRIzol Reagent (Life
Technologies). cDNA was generated with minimally 500ng of total
RNA, using oligo-d(T) primers and MMLV RT enzyme
(Promega) and amplified with Taq polymerase (Promega) and
sequence-specific primers targeted at HSPA1A, HPSA1B, or
GAPDH PCR products, generated under non-saturating condi-
tions. The products were separated by PAGE and were detected
by ethidium bromide staining and subsequently visualized using
UV. To quantify the bands obtained via RT-PCR, we applied
ImageJ software based analysis (http://rsb.info.nih.gov/ij/). The
area under curve (AUC) of the specific signal was corrected for the
AUC of the housekeeping gene control.
Female 8 week old BALB/c mice were subjected to the
indicated treatment and total RNA was purified out of total skin
grafts using RNeasy+ kit (Qiagen). RNA was transcribed to cDNA
with iScript cDNA synthesis kit (Bio-Rad). RT-qPCR analysis of
animal and cellular samples was performed using the Lightcycler
480 system and Lightcycler qPCR reagents (Roche), to assay
specific GR, HSPA1A, HSPA1B, IL8, GAPDH, b-actin, cyclo-
philin, 36B4, 28S, RPL13a, HMBS, ACTB mRNA levels. qPCR
was performed in triplicate. All primer sequences are available
upon request. Specific signal was normalized to housekeeping
control.
Protein Analyses & Antibodies
For Western analysis, total cell lysates were prepared using SDS
sample buffer (50mM Tris pH6.8; 2% SDS; 10% glycerol;
bromophenol blue, 100mM DTT) or TOTEX buffer (20 mM
Hepes/KOH pH 7.9; 0.35 M NaCl; 20% glycerol; 1% NP40;
1 mM MgCl2; 0.5 mM EDTA; 0.1 mM EGTA; 2mM pefabloc;
10mg/ml aprotinin; 5mM DTT) followed by standard Western
blotting and antibody probing procedures (Santa Cruz Biotech-
nology). Samples prepared with SDS sample buffer are loaded at
an equal volume of maximally 30ml and equal loading is assayed
via a loading control. Samples prepared with TOTEX buffer are
analysed for protein concentration via a Bradford analysis [33]
and maximally 40mg is loaded for Western blot analysis.
The antibodies (Abs), used in the Western blot analyses, were
directed against GR, PARP, NF-kB p65, IkBa and tubulin (Santa
Cruz Biotechnology), b-catenin (Sigma-Aldrich) and phosphory-
lated S6 ribosomal protein (Cell Signalling Technology). Antibod-
ies directed against inducible Hsp70 were purchased via different
companies, but it was verified that all recognize inducible Hsp70:
anti-Hsp72 SPA-810 monoclonal Ab (Stressgen) and anti-Hsp70
polyconal Ab(Santa Cruz Biotechnologies; sc-1060). All primary
antibodies were used at 1/1000 dilutions; except anti-tubulin,
which was used at 1/2000. The secondary antibodies were used
with the following dilutions: anti-Mouse IgG-HRP (NA931V, GE-
Healthcare UK Limited) at 1/3000, anti-Rabbit IgG-HRP
(NA935V, GE-Healthcare UK Limited) at 1/4000, anti-Rat
IgG-HRP (NA934V, GE-Healthcare UK Limited) at 1/1000,
and anti-goat IgG-HRP (sc-2020, Santa Cruz Biotechnologies)
also at 1/1000.
To quantify the bands obtained via Western blot analysis, we
applied band densitometric analysis via ImageJ software (http://
rsb.info.nih.gov/ij/). The area under curve (AUC) of the specific
signal was corrected for the AUC of the loading control. The value
for the ‘Solv’ condition was set as 1 and other conditions were
recalculated correspondingly to allow ratio comparisons. For the
Hsp70 cell lysate ELISA, we used the EKS-700B Hsp70 ELISA kit
according to the manufacturer’s instructions (Stressgen).
LC-MS/MS Analysis
HEK293T cells were transiently transfected with 10mg Flag-
tagged GR using the calcium phosphate transfection method. 24
hours after transfection and after induction with solvent or
Compound A (10mM) for 3h, cells were lysed either in 1ml NP40
non-denaturing buffer (50 mM Tris.HCl pH 7.5; 125 mM NaCl;
5% glycerol; 0.2% NP40; 1.5 mM MgCl2; and cOmpleteH
protease inhibitor cocktail (1 tablet/50ml buffer)) or 1ml Buffer
A (10mM Hepes pH 7.5; 10mM KCl; 1.5mM MgCl2; 0.1% NP-
40; 0.5mM DTT; and for cOmpleteH protease inhibitor cocktail
cocktail (1 tablet/50ml buffer)). Input controls (50ml/sample) of
either buffer were kept aside for control western blot analyses.
Flag-tagged GR was immunoprecipitated with 40ml Flag beads
overnight. Cell lysates in NP40 non-denaturing buffer were
processed as follows: after 5 washes with 5mM TEAB (triethy-
lammonium bicarbonate) buffer, elution was performed with
600 ml of 100 mg/ml Flag peptide in 5mM TEAB buffer. Cell
lysates in buffer A were processed as follows: after 5 washes with
NH4HCO3 (50mM pH 8), elution was done with 450 ml
ammoniumhydroxide (NH4OH) (1%).
Reagents and solvents were purchased from Sigma-Aldrich (St.
Louis, MO, USA), except acetonitrile (Baker, Center Valley, PA,
USA) and formic acid (Biosolve, Valkenswaard, The Netherlands),
and used without further purification, unless specified. H2O for
(HPLC) buffers was produced with a Millipore (Billerica, MA,
USA) RIOs-DI water purification system, coupled with the MilliQ
Compound A and Heat Shock Protein 70
PLOS ONE | www.plosone.org 3 July 2013 | Volume 8 | Issue 7 | e69115
Reference A+ system equipped with a 22 mm filter and a C18
column to remove organic impurities.
Immunoprecipated samples were dried completely in a rota-
tional vacuum concentrator (RVC 2–33 IR, Martin Christ,
Osterode am Harz, Germany). The residue was reconstituted in
500 ml of 50 mM TEAB buffer (pH 8) and the resulting solution
was heated at 95uC for 10 min. After cooling on ice for at least
5 min, trypsin (2 mg, Sequencing Grade Modified Trypsin,
Porcine, Promega, Leiden, The Netherlands) was added and the
samples were overnight incubated at 37uC. Samples were again
dried completely in a rotational vacuum concentrator and
reconstituted in 20 ml of 2% acetonitrile in 0.1% TFA. Samples
were centrifuged for 10 minutes at 15000 g, and the supernatant
was transferred to a vial for LC-MS/MS analysis.
The samples were analyzed on a LC-MS/MS system consisting
of an Ultimate 3000 RSLC nano (Dionex, Amsterdam, The
Netherlands) in-line connected to a LTQ Orbitrap Velos (Thermo
Fisher Scientific, Bremen, Germany). The sample was loaded on a
trapping column (made in-house, 100 mm internal diameter
(I.D.)620 mm, 5 mm beads C18 Reprosil-HD, Dr. Maisch). After
back-flushing from the trapping column, the sample was loaded on
a reverse-phase column (made in-house, 75 mm I.D6150 mm,
5 mm beads C18 Reprosil-HD, Dr. Maisch) with solvent A (0.1%
trifluoroacetic acid, 2% acetonitrile), and were separated with a
linear gradient from 2% solvent A’ (0.1% formic acid) to 55%
solvent B’ (0.1% formic acid and 80% acetonitrile) at a flow rate of
300 nl/min followed by a wash reaching 100% solvent B.
The mass spectrometer was operated in data-dependent mode,
automatically switching between MS and MS/MS acquisition for
the ten most abundant peaks in a given MS spectrum. Full scan
MS spectra were acquired in the Orbitrap at a target value of 1E6
with a resolution of 60,000. The ten most intense ions were then
isolated for fragmentation in the linear ion trap, with a dynamic
exclusion of 30 s. Peptides were fragmented after filling the ion
trap at a target value of 1E4 ion counts. The mass spectrometer’s
nanospray source was expanded with an Active Background Ion
Reduction Device (Abird, ESI Source Solutions). From the MS/
MS data in each LC run, Mascot Generic Files were created using
the Mascot Distiller software (version 2.4.3.3, Matrix Science,
www.matrixscience.com/Distiller). While generating these peak
lists, grouping of spectra was allowed in Distiller with a maximum
intermediate retention time of 30 s and a maximum intermediate
scan count of 5 was used where possible. Grouping was done with
0.005 m/z precursor tolerance. A peak list was only generated
when the MS/MS spectrum contained more than 10 peaks. There
was no de-isotoping and the relative signal to noise limit was set at
2. These peak lists were then searched with the Mascot search
engine (MatrixScience) using the Mascot Daemon interface
(version 2.4.0, Matrix Science). Spectra were searched against
the human subsection of the Swiss-Prot database (version 2013_01
of UniProtKB/Swiss-Prot protein database containing 20,232
human sequence entries). Variable modifications were set to
methionine oxidation, pyro-glutamate formation of amino termi-
nal glutamine, and acetylation of the N-terminus and lysine side
chains. The mass tolerance on precursor ions was set to 10 ppm
(with Mascot’s C13 option set to 1), and on fragment ions to 0.5
Da. The peptide charge was set to 1+,2+,3+ and the instrument
setting was put on ESI-TRAP. Enzyme was set to trypsin, allowing
1 missed cleavage, and cleavage was also allowed when arginine or
lysine are followed by proline. Only peptides that were ranked one
and scored above the threshold score, set at 99% confidence, were
withheld. All data management was done by ms_lims [34].
siRNA Transfection
A549 cells were seeded and the following day transiently
transfected using the calcium phosphate precipitation technique as
described before [35]. As indicated, cells were either transfected
with siRNA control, siRNA GR (NR3C1) or a combination of
siRNA HSPA1A and HSPA1B (Dharmacon). Specific sequences
and order numbers can be found in Table S1. Cells were
incubated with the respective transfection mixtures overnight
(16h). The following day, medium was replaced with DMEM,
supplemented with 10% fetal calf serum, and cells were left to rest
for 24h. Subsequent to the appropriate inductions, total RNA was
isolated using TRIzol Reagent (Invitrogen, Life Technologies). To
control for siRNA efficiencies, we collected control RNA samples
Table 1. Overview of identified heat shock proteins via LC-MS/MS.
Identified proteins Number of spectra Run
Heat shock 70 kDa protein 1A/1B (HSP71_HUMAN) 99 CpdA (FLAG)
Heat shock 70 kDa protein 1A/1B (HSP71_HUMAN) 48 CpdA (NH4OH)
Heat shock 70 kDa protein 1A/1B (HSP71_HUMAN) 52 NI (FLAG)
Heat shock 70 kDa protein 1A/1B (HSP71_HUMAN) 50 NI (NH4OH)
Heat shock cognate 71 kDa protein (HSP7C_HUMAN) 45 CpdA (FLAG)
Heat shock cognate 71 kDa protein (HSP7C_HUMAN) 45 CpdA (NH4OH)
Heat shock cognate 71 kDa protein (HSP7C_HUMAN) 43 NI (FLAG)
Heat shock cognate 71 kDa protein (HSP7C_HUMAN) 37 NI (NH4OH)
Heat shock protein HSP 90-alpha (HS90A_HUMAN) 1 CpdA (FLAG)
Heat shock protein HSP 90-alpha (HS90A_HUMAN) 1 CpdA (NH4OH)
Heat shock protein HSP 90-beta (HS90B_HUMAN) 8 CpdA (FLAG)
Heat shock protein HSP 90-beta (HS90B_HUMAN) 7 NI (FLAG)
Heat shock protein HSP 90-beta (HS90B_HUMAN) 3 NI (NH4OH)
HEK293T cells were transfected with Flag-hGRa via calcium phosphate and following stimulation with either solvent (NI) or 10mM CpdA (CpdA), immunoprecipitated
using Flag beads (plasmid and methodology described in [7]. Two identical set-ups were done in parallel, yet, using two different elution methods, via NH4OH, as
indicated, or via the Flag peptide (FLAG, 100mg/ml). The Swiss-Prot accession is indicated in the protein description field. Per protein, the number of identified MS/MS
spectra (at 99% confidence settings (Mascot)) is indicated.
doi:10.1371/journal.pone.0069115.t001
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and total protein cell lysates (SDS Sample buffer) of control wells.
RNA samples and control protein samples were analyzed, as
described above.
Immunofluorescence
A549 cells, seeded on coverslips and incubated in Optimem
(Gibco) for 48h, were induced as indicated. The protocol
regarding fixation, permeabilization and staining was described
[5]. Endogenous HSF1 or NF-kB p65 was visualized using a
specific Ab followed by Alexa Fluor 488 goat a-rabbit IgG
(Molecular Probes) secondary Ab. The antibodies directed against
HSF1 and NF-kB p65 were purchased via Cell Signaling
Technology and Santa Cruz, respectively. Cell nuclei were stained
with DAPI (0.4mg/ml). Alexa fluor 488 excitation or UV-
illumination via an Axiovert 200M immunofluorescence micro-
scope (Zeiss) allowed recording of HSF1 or NF-kB p65, or DAPI
signal, respectively, with a Zeiss Axiocam mMR. Images were
processed using Axiovision Release 4.6.3-SP1 software.
Subcellular distribution of endogenous NF-kB p65 was analyzed
using ImageJ software integrated density analysis of cells in various
images of the same sample. A representative image is shown. The
distribution of NF-kB p65 in each cell is expressed as the
percentage of nuclear NF-kB p65 on a cell total of 100% NF-kB
p65 and total results of each experiment are presented as a scatter
dot plot.
Chromatin Immunoprecipitation (ChIP) Assay
A549 cells were starved in 0% DMEM for 48 hours. After
treatments, cells were subjected to a ChIP assay against HSF1, as
described [36]. ChIP analysis of endogenous HSF1 was performed
with a-HSF1 antibody (Cell Signaling Technology). Normal rabbit
IgG (Santa Cruz) was used as a negative control in ChIP. The
amount of sonicated protein:DNA complexes, present before
immunoprecipitation (IP), is indicated by the input controls. Final
DNA samples of bound immunoprecipitated and input fraction
were purified via a QIAquick PCR purification kit (QIAGEN).
Purified DNA samples, enriched with the immunoprecipitated
protein, and input control DNA samples were subjected to qPCR
in triplicate. Primer sequences are available upon request. Data
obtained from immunoprecipitated samples were corrected for the
signal of the respective input control and final integrated results
were presented as ‘Relative recruitment’.
Figure 1. Compound A is a selective GR modulator with NF-kB
repressive capacity. (A) Compound A chemical structure (B) A549
cells, transiently transfected with p(IL6kB)350hu.IL6P-luc+, were treated
with solvent (Solv), DEX (1mM) or CpdA (1mM or 10mM) for 2h.
Subsequently, cells were induced with TNF (2000 IU/ml) for 6h where
indicated. b-gal control-corrected results were presented as relative
reporter gene activity with the condition Solv/TNF set at 100. Statistical
analysis (ANOVA with Tukey’s multiple comparison post test) was
performed to show significant difference with the TNF condition for
selected conditions (*** p,0.001). (C) A549 cells, transiently transfected
with p(GRE)250-luc+, were treated with Solv, DEX (1mM) or CpdA (1mM
or 10mM) for 8h. b-gal control-corrected results were presented as
relative reporter gene activity with the condition Solv set at 1. Statistical
analysis (ANOVA with Tukey’s multiple comparison post test) was
performed to show significant difference with the Solv condition (ns
not significant; *** p,0.001). Results are shown +/2SD. Figures in (B)
and (C) are representative of at least 3 independent experiments. (D)
Schematic model of gene modulatory GC and CpdA effects. While
classic GCs can transactivate GRE-regulated genes and impede gene
expression of specific target genes via a tethering transrepression
mechanism (left panel), CpdA drives GR into a monomer formation that
does not allow transcactivation of GRE-regulated gene expression.
CpdA liganded GR can, however, still repress gene expression via
transrepression (right panel).
doi:10.1371/journal.pone.0069115.g001
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Figure 2. Both Compound A and heat shock diminish NF-kB-driven gene expression and NF-kB activation. (A) A549 cells, starved for
48h, were pretreated for 1.5h with solvent (Solv), DEX (1mM), CpdA (10mM) or subjected to heat shock treatment (1h at 43uC and 309 recovery at 37uC),
ensued with TNF (2000IU/ml) for 5.5h. Isolated total RNA was subjected to RT-qPCR assaying IL8 mRNA levels, normalized to cyclophilin household
gene mRNA levels. The TNF condition was set at 100 and results were recalculated accordingly. These results are representative of 2 independent
experiments. Statistical analysis (ANOVA and Tukey multiple comparison post test) were performed for selected pair-wise comparisons. (B) A549 cells,
starved for 48h, were pretreated for 2h with solvent (Solv), DEX (1mM) or CpdA (10mM), after which TNF(2000IU/ml) was added as indicated. Western
blot analysis of total cells lysates detects IkBa protein, with NF-kB p65 as loading control. This figure is representative for 2 independent experiments.
(C) A549 cells, starved for 48h, were untreated or heat-shocked at 43uC for 2h. Ensuing, cells were treated by TNF (2000IU/ml) for the indicated times.
Total cell lysates were analyzed as in (B), with tubulin as loading control. Results were obtained on 2 separate blots in one experiment. (D) A549 cells,
starved for 48h in Optimem, were pretreated for 2h with Solv, DEX (1mM), CpdA (10mM) or 2h heat shock (HS) at 43uC. Subsequently, TNF (2000IU/ml)
was added for 309, where indicated. After washing, fixation, and permeabilization, indirect immunofluorescence detects endogenous NF-kB p65.
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Statistical Analyses
Statistical analyses were performed with a one-way analysis of
variance (ANOVA) and Tukey’s multiple comparison post test, an
unpaired t-test or a non-parametric Mann-Whitney-U test, where
appropriate, using the asymptotic significant P-values. Error bars
indicate SD.
All materials and methods, as described in above are also valid
for the figures S1, S2, S3, S4, S5, S6, S7, S8, S9, and S10 and
tables S1 and S2. Additional materials en methods to understand
figures S1, S2, S3, S4, S5, S6, S7, S8, S9, and S10 and tables S1
and S2are added in support.
Results
Compound A is a Selective GR Modulator with NF-kB
Repressive Capacity
To confirm the selective GR modulator status of CpdA (or 2-(4-
acetoxyphenyl)-2-chloro-N-methyl-ethylammonium chloride (Figure 1A) in
A549 human epithelial cells, we performed reporter gene analyses
with transiently transfected cells. The administration of the
synthetic glucocorticoid dexamethasone (DEX) or CpdA to a
TNF-stimulated NF-kB-driven promoter represses the reporter
gene activity in a statistically significant manner (Figure 1B).
Alternatively, whereas DEX can potently induce GRE-regulated
promoter activity, CpdA has no significant effect on the reporter
gene activity of p(GRE)250-luc+ (Figure 1C). Similar data were
previously obtained in stably transfected L929sA cells [5]. To sum
up, CpdA can be referred to as a selective GR modulator since it
represses NF-kB-driven gene expression without inducing the
dimeric GR-mediated upregulation of GRE-regulated genes
(Figure 1D).
Both Compound A and Heat Shock Diminish NF-kB-
driven Gene Expression and NF-kB Activation
As it is described that heat shock or elevated Hsp70 can impede
NF-kB-mediated transcriptional activity via impairing IkBa
proteasomal degradation and limiting the subsequent NF-kB
p65 translocation [18,37,38], we wondered whether the CpdA-
evoked repression of NF-kB-driven gene expression could be
mediated by a similar mechanism. Hereto, we first established that
all the stimuli we used, i.e. heat shock, CpdA and DEX are able to
significantly inhibit TNF-stimulated NF-kB-driven gene expres-
sion of IL8 (Figure 2A) and IL6 (Figure S1) in A549 cells. To
explore potential mechanistic parallels, we first assayed whether
CpdA could impede the TNF-stimulated IKK-mediated IkBa
degradation in A549 cells. As expected, TNF addition prompted a
complete degradation of IkBa, the level of which starts to rise
again after 609 of TNF treatment (Figure 2B-C). The GC DEX
did not affect TNF-induced IkBa degradation in A549 cells
(Figure 2B), confirming our previous findings in L929sA cells [32].
In contrast, CpdA administration resulted in an incomplete IkBa
degradation after TNF stimulation (Figure 2B). As expected from
literature-based evidence in other cell systems, a heat shock
treatment, leading to HSF1 activation and highly elevated Hsp70
protein levels, can indeed lead to a total block of the TNF-
stimulated proteasomal IkBa degradation (Figure 2C). Because the
IkBa-NF-kB p65 association controls the cytoplasmic localization
of NF-kB p65 [1], we subsequently investigated the effects of GCs,
CpdA and heat shock on the TNF-stimulated NF-kB p65 nuclear
translocation in A549 cells. We observed that 309 of TNF
treatment triggers a subcellular shift of NF-kB p65 from the
cytoplasm to the nucleus (Figure 2D, lanes 1vs2). Furthermore, we
noticed that DEX does not affect the TNF-induced nuclear import
of NF-kB p65 (Figure 2D-E: lanes 2vs4). In contrast, pretreatment
with CpdA slightly diminishes the TNF-stimulated NF-kB p65
translocation (Figure 2D-E: lanes 2vs6). Furthermore, pre-treat-
ment with heat shock reduces the TNF-induced nuclear translo-
cation of NF-kB p65 in a significant manner (Figure 2D-E: lanes
2vs8). Cytoplasmic localization of NF-kB p65 in unstimulated cells
was not altered by induction with DEX, CpdA or heat shock
(Figure 2D: lanes 1vs3,5&7). In line with these observations, CpdA
hampers the TNF-induced IkBa degradation and/or NF-kB p65
nuclear translocation also in fibroblast-like synovial (FLS) cells
[39], primary microglial cells [40] and L929sA fibrosarcoma cells
(Figure S2).
To summarize, CpdA reduces the TNF-stimulated IkBa
degradation and NF-kB p65 translocation from the cytoplasm to
the nucleus. Heat shock treatment totally abolishes TNF-
stimulated IkBa degradation and reduces the TNF-induced
nuclear translocation of NF-kB 65, more profoundly. Correspond-
ingly, both treatments negatively impact NF-kB-driven gene
expression.
Hsp70 is Required to Allow the anti-inflammatory Activity
of Compound A
To specifically address the possible role of Hsp70 in the CpdA-
mediated anti-inflammatory action mechanism, we knocked down
Hsp70 in A549 cells via transfection of siRNA HSPA1A and
siRNA HSPA1B, targeting Hsp70 mRNA. The distinct genes
HSPA1A and HSPA1B, located in close proximity on chromo-
some 6 and displaying a 98% sequence similarity, both code for
Hsp70 protein. Tests to validate the efficacy of specific siRNA
targeting Hsp70 in comparison to non-targeting siControl showed
via RT-qPCR that HSPA1A and HSPA1B mRNA levels were
significantly knocked down (Figure 3A, left panel) and that,
consequently, Hsp70 protein was nearly completely abolished
(Figure 3A, right panel). Analysis of TNF-stimulated IL8 gene
expression levels demonstrated, as expected, that CpdA can
significantly inhibit IL8 gene transcription when cells were
transfected with non-targeting siControl (Figure 3B: lanes 3vs4).
However, when cellular Hsp70 levels were knocked down via
transfection of Hsp70-targeting siRNA, CpdA completely failed to
exert its anti-inflammatory effect on IL8 gene expression levels
(Figure 3B: lanes 7vs8). Similar results were obtained for IL6 gene
expression levels (Figure S3). In summary, adequate cellular levels
of Hsp70 protein are required to allow CpdA-mediated repression
of pro-inflammatory gene expression.
Compound A Augments Hsp70 Gene Expression
Since CpdA clearly shows parallels to heat shock with regard to
its anti-inflammatory mechanism and since CpdA’s anti-inflam-
matory mechanism relies on the presence of Hsp70, we studied the
effect of CpdA on Hsp70 gene expression. First, we checked
whether the selected primers could indeed detect heat shock-
inducible Hsp70 and whether the cell system is susceptible to heat
shock-induced Hsp70 upregulation. Total RNA was isolated from
A549 cells and resulting samples were subjected to RT-PCR for
the detection of HSPA1A mRNA levels. Detection of GAPDH
DAPI staining indicates the nuclei. Additionally, we present overlays. This figure is representative for 2 independent experiments. (E) ImageJ
integrated density analysis of the TNF-treated conditions in (D) allows statistical analysis (Mann-Whitney U test) and we show the P-value of
comparisons to the Solv/TNF condition. These results are representative of 2 independent experiments.
doi:10.1371/journal.pone.0069115.g002
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mRNA levels served as control for input RNA and RT efficiency.
From Figure 4A it is clear that in A549 cells heat shock clearly
leads to an increase in HSPA1A gene transcription levels, which
increases even more if cells are left to recover at 37uC. Next, we
found that CpdA indeed increases the expression of HSPA1A in
A549 cells (Figure 4B). Of note, HSPA1A gene expression levels
are even higher when the cells were stimulated with CpdA
combined with heat shock than when the cells were induced with
heat shock alone (Figure 4B), pointing to possible different and
hence additive molecular induction mechanisms. Furthermore,
CpdA could also elevate the mRNA levels transcribed of the
related HSPA2 and HSPA6 genes (Figure S4). Concisely, CpdA
can substantially elevate various Hsp70 gene expression levels in
A549 cells. Further confirmation of these data was found in the
human breast carcinoma cell line MCF-7 (Figure S5) and in vivo
(Figure 4C). Indeed, complete skins from i.p. injected BALB/c
mice were harvested after 24h of induction. As expected, also in
these samples, Compound A concentration-dependently enhances
HSPA1A mRNA levels (Figure 4C), overall suggesting a cell- and
species-independent effect.
De novo Hsp70 production is not Necessary for CpdA’s
anti-inflammatory Action Mechanism
Since CpdA is able to stimulate Hsp70 gene transcription, we
went on to investigate whether CpdA-induced Hsp70 protein
synthesis is required for the anti-inflammatory activity of CpdA.
Hereto, we treated A549 cells with cycloheximide (CHX), an
inhibitor of translational elongation and thus new protein synthesis
and then analyzed the anti-inflammatory potential of CpdA
toward the TNF-stimulated IL8 gene expression. Remarkably, the
CpdA-mediated repression of TNF-induced IL8 gene expression
was maintained when new protein synthesis was blocked via CHX
(Figure 5A). Functionality of CHX could be confirmed by a
Western blot experiment ran in parallel, in which we visualized the
short-lived b-catenin protein (Figure S6).
Ensuing, we explored the effects of CpdA on Hsp70 protein
levels. First, we confirmed that heat shock treatment elevated
Hsp70 protein production in A549 cells (Figure 5B). In
correspondence with Figure 4A, the detected Hsp70 Western blot
signal was augmented by heat shock treatment and increased
further, when cells were left to recover at 37uC (Figure 5B).
However, contrary to our expectations, 6h or 24h CpdA
treatments of A549 cells did not appear to elevate Hsp70 protein
levels (Figure 5C). Densitometric quantification analysis of
multiple Western blot analyses clearly confirmed these results
(Figure 5D). Moreover, independent Hsp70 ELISAs corroborated
this yet again (Figure 5E). Similar data via Hsp70 ELISA were
obtained from L929sA cell lysates (Figure S7). Regardless of the
fact that Compound A appears unable to elevate the Hsp70
protein level, every assay shows a robust increase in Hsp70 protein
levels after heat shock treatment.(Figure 5C-E, Figure S7).
To explore whether the lack of a CpdA-induced Hsp70 protein
level rise can be attributed to a rapid degradation of the Hsp70
protein, we analyzed A549 and PC-3 cells cells using co-treatments
with MG132, an inhibitor of proteasomal degradation. We could
show that addition of MG132 does not allow for a CpdA-mediated
increase in Hsp70 protein (Figure 6A). To investigate whether
CpdA enforces a general block on translation, we analyzed the
effects of CpdA on the protein levels of b-catenin, a protein with a
short half-life of approximately 2–3h, depending on the cell type
[41,42,43] (Figure 6B). Treatment of A549 cells with CpdA does
not result in a degradation of b-catenin, not even after a 48h
treatment with CpdA (Figure 6B). Similar results were obtained in
PC-3 cells (Figure S8A). Additionally, we explored whether or not
Figure 3. Hsp70 is required to allow the anti-inflammatory
activity of Compound A. (A) A549 cells were transfected with
siControl or siRNA targeting HSPA1A and HSPA1B (siHsp70). Total RNA
or total protein extracts were prepared 48h post transfection. Purified
mRNA was subjected to RT-qPCR detecting HSPA1A or HSPA1B gene
expression levels and specific results were normalized to housekeeping
controls cyclophilin and 28S, as presented in the left panel. For
siControl-transfected samples gene expression levels were set at 100%.
SiHsp70-transfected results were recalculated accordingly. Statistical
analysis (unpaired t-test) was performed to show significant difference
between siControl and siHsp70 conditions (*** p,0.001). In the right
panel, total cell lysates were subjected to Western blot analysis to
detect Hsp70 protein levels. Detection of tubulin served as loading
control. (B) In parallel with (A), A549 cells were transfected with
siControl or siHsp70. 41h post transfection, cells were pretreated with
Solv or CpdA (10mM) for 2h, after which ensued a 6h TNF (2000IU/ml)
treatment. Purified mRNA was subjected to RT-qPCR detecting IL8 gene
expression levels and specific results were normalized to housekeeping
controls cyclophilin and 28S. The condition Solv (siControl) was set as 1
to allow ratio comparisons. Statistical analysis (ANOVA with Tukey’s
multiple comparison post test) was performed to show significant
difference for selected pair wise comparisons (ns not significant; **
p,0.01; *** p,0.001).
doi:10.1371/journal.pone.0069115.g003
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CpdA could affect the expression levels of the constitutively
expressed galactosidase reporter gene in stably transfected L929sA
cells. As expected, CpdA does not significantly affect these
galactosidase levels, again indicating that CpdA does not inhibit
translation in general (Figure S8B).
In summary, the anti-inflammatory mechanism of CpdA does
not appear to depend on de novo (Hsp70) protein synthesis.
The Glucocorticoid Receptor Interacts with Hsp70 and
Hsp90
Mammalian Protein-Protein Interaction Trap (MAPPIT) is a
two-hybrid interaction mapping technique based on the functional
complementation of a type I cytokine receptor signaling pathway,
using a STAT3-dependent luciferase reporter gene as a read-out.
MAPPIT relies on a dysfunctional JAK-STAT signaling pathway,
of which the activity is only restored when a protein–protein
interaction between specific ‘bait’ and ‘prey’ chimeras occurs [44].
Since it operates in intact human cells, MAPPIT allows for
analysis of protein:protein interactions under different physiolog-
ical conditions, e.g. untreated versus DEX- or CpdA-treated cells.
As expected, the interaction between unliganded GRa and Hsp90
or Hsp70 (Figure 7) yielded a strong signal in MAPPIT. These
interactions were lost upon stimulation with DEX, as expected,
but retained upon CpdA induction (Figure 7). There was no
interaction (no signal) with the irrelevant bait, confirming that the
observed interactions are indeed GRa-specific.
These findings were verified via mass spectrometry analysis,
using a shotgun proteomics approach, following the elution of
immunoprecipitated Flag-tagged GRa that was overexpressed in
HEK293T cells. Table 1 demonstrates that the number of
identified MS/MS spectra for associated Hsp70 and Hsp90
proteins was comparable between solvent-treated and CpdA-
treated cells (Table 1 and Table S2, listing per identified heat
shock protein the corresponding peptides as well as the number of
MS/MS spectra per identified peptide). Taken together, CpdA
does not lead to dissociation of Hsp70 from the Glucocorticoid
Receptor.
Compound A Increases Hsp70 Promoter Activity Dose-
dependently and Transiently
Although an increase in Hsp70 protein does not seem to play a
role in CpdA’s overall anti-inflammatory mechanism, we were
intrigued by the rarely reported gene stimulatory effect of CpdA.
Therefore, we decided to explore the promoter regulation of
Hsp70 in more detail. To directly investigate the effects of CpdA
on Hsp70 promoter activity, we created a L929sA cell line in
which the inducible murine Hsp70i-luc reporter gene construct
was stably integrated in the genome. First, we tested for heat shock
inducibility of the system and could confirm that the stably
transfected mHsp70i-luc reporter gene construct responded
positively to a heat shock stimulus (Figure 8A). Next, we evaluated
Figure 4. Compound A augments Hsp70 gene expression. (A)
A549 cells were left untreated or were induced with heat shock (HS) at
43uC for 2h either or not followed by 4h recovery time (Rec) at 37uC.
Isolated total RNA was subjected to RT-qPCR for the detection of
HSPA1A, normalized to cyclophilin housekeeping control. The non-
induced condition was set as 1 to allow ratio comparisons. Statistical
analysis (ANOVA with Tukey’s multiple comparison post test) was
performed for selected pair wise comparisons (ns not significant;
*p,0.05; ** p,0.01). These results are representative of three
independent experiments. (B) A549 cells, treated with solvent (Solv)
or CpdA (10mM), were either incubated at 37uC for 6 hours or subjected
to the following temperature protocol : 2 hours at 37uC (pre-induction),
followed by 2 hours at 43uC heat shock (HS) and lastly 2 hours at 37uC
(recovery; Rec). Isolated total RNA was subjected to RT-PCR for the
detection of HSPA1A and control GAPDH gene expression levels. The
displayed bands were detected from one single gel. The respective
bands were quantified using ImageJ software and normalized to
GAPDH control expression levels. Solv was set as 1 and all other
conditions were recalculated relative to this condition and expressed as
relative mRNA expression level. The figure is representative for 2
independent experiments. (C) Eight week old female BALB/c mice were
injected intraperitoneally with either PBS as a control or CpdA dissolved
in PBS (5mg/kg or 10mg/kg) and 24h later total skin samples were
resected and their respective mRNA samples were subjected to RT-
qPCR analysis assaying for HSPA1A gene expression levels and
normalized to RPL13a, HMBS and ACTB housekeeping controls. The
non-induced condition was set as 1 to allow ratio comparisons.
Statistical analysis (Mann Whitney-U-test) was performed for selected
pair wise comparisons (ns not significant; ** p,0.01).
doi:10.1371/journal.pone.0069115.g004
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the response of this inducible system to CpdA stimulation. We
could demonstrate that CpdA concentration-dependently increas-
es Hsp70 promoter activity, showing a significant elevation from a
5mM concentration onwards (Figure 8B). Furthermore, experi-
menting with variable induction times shows that a 6h CpdA
treatment of the L929sA cells, stably transfected with mHsp70i-
luc, significantly augments Hsp70 promoter activity, whereas
incubations with CpdA for 24h or 48h did not affect Hsp70
promoter activity (Figure 8C). This transient time frame was
confirmed when assaying A549 mRNA coding for HSPA1A
(Figure 8D) and HSPA2 and HSPA6 (Figure S4), confirming and
validating our earlier RT-PCR data (Figure 4B). Similar data were
also obtained in PC-3 prostate adenocarcinoma cells (Figure 8E).
In summary, Hsp70 promoter activity is concentration-depen-
dently and transiently enhanced by CpdA in different cell lines and
species.
CpdA stimulation of the Hsp70 gene promoter occurs via
a GR-dependent mechanism
As CpdA is a selective GR modulator, driving GR into a
monomeric formation [7], we wondered whether the stimulatory
Figure 5. Hsp70 production is not necessary for CpdA’s anti-inflammatory action mechanism. (A) A549 cells, starved for 48h, were left
untreated or were pretreated for 309 with cycloheximide (CHX)(20mg/ml), after which solvent (Solv) or CpdA (10mM) was added for 1.5h.
Subsequently, cells were incubated with TNF(2000IU/ml) for 5h. Isolated total mRNA was subjected to RT-qPCR detecting IL8, normalized to GAPDH
levels. Solv was set as 1 and other conditions were recalculated accordingly. Statistical analysis (ANOVA with Tukey’s multiple comparison post test)
was performed for selected pair wise comparisons (**p,0.001; **p,0.001). This figure is representative for 2 independent experiments. (B) A549 cells
were heat-shocked (HS) at 43uC for 2h either or not followed by recovery time (Rec) at 37uC. (C) A549 cells were treated with Solv or CpdA (10mM) for
6h or 24h or heat-shocked at 43uC for 2h, after which cells were left to recover at 37uC for 2h (HS+Rec). (B)(C) Total cell protein extracts were
subjected to Western blot analysis detecting Hsp70, with NF-kB p65 or tubulin as loading controls. These images are representative for at least 3
independent experiments. (D) shows the averaged band densitometric analysis (ImageJ) of 8 independent Hsp70 Western blot analyses. Specific
Hsp70 signal was corrected for sample loading. Solv was set as 1 to allow ratio comparisons. Statistical analysis (ANOVA with Tukey’s multiple
comparison post test) was performed for selected pair wise comparisons (ns not significant; ***p,0.001). (E) A549 cells were treated with solvent or
CpdA (10mM) for 4h,8h or 24h or heat-shocked at 43uC for 2h, after which cells were left to recover at 37uC for 2h or 4h(HS+Rec). Total cell protein
lysates were analyzed via Hsp70 ELISA. Statistical analysis (ANOVA with Tukey’s multiple comparison post test) was performed for selected pair-wise
comparisons (ns not significant; ***p,0.001). This figure represents averaged data of 4 independent experiments.
doi:10.1371/journal.pone.0069115.g005
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effect of CpdA on Hsp70 gene expression directly relies on the
presence of GR. Hereto, we transfected A549 cells with siRNA
targeting GR mRNA, resulting in a strong knockdown of GR
mRNA and protein levels (Figure 9A). Analysis of HSPA1A gene
expression levels in the non-targeting siControl transfected
samples showed that induction with CpdA again is able to
stimulate HSPA1A gene expression (Figure 9B), once more
confirming and validating our RT-PCR data (Figure 4B). How-
ever, when we knocked down GR mRNA and protein levels,
induction with CpdA failed to stimulate HSPA1A gene expression
levels (Figure 9B). Based on these data, CpdA stimulation of
HSPA1A gene expression can be considered as a GR-dependent
phenomenon. Further analysis was performed at the promoter
level via a GR-targeting Chromatin immunoprecipitation (ChIP),
looking at promoter sites flanking the HSE locus in the HSPA1A
gene promoter and the GRE locus in the glucocorticoid-induced
leucine zipper (GILZ) gene promoter. Remarkably, the data
revealed that CpdA did not direct the GR to the HSPA1A gene
promoter, in contrast to DEX (Figure 9C). Focusing on a classical
GRE-regulated GILZ promoter, a similar DEX-, but not CpdA-
induced increase in GR occupancy was observed, as expected,
confirming the functionality of our assay (Figure 9D). Also heat
shock treatment failed to support GR occupancy at the HSPA1A
or GILZ gene promoters (Figure 9C-D). In conclusion, CpdA
stimulation of the Hsp70 gene promoter occurs via a GR-
dependent mechanism, but without GR occupancy at Hsp70-
coding gene promoters.
Compound A Does not Activate HSF1
As heat shock is known to stimulate Hsp70 gene expression via
the activation of the transcription factor HSF1, and since GR
seems to be an indirect contributor for CpdA-activated Hsp70
gene expression, we hypothesized CpdA may be able to exert
effects on HSF1. Therefore, we analyzed via indirect immunoflu-
orescence the endogenous HSF1 protein signal in A549 cells. As
expected, we could show that heat shock treatment for 30min
(Figure S9) and 1h induces the appearance of bright nuclear foci of
HSF1, also called nuclear stress granules, indicated by white
arrows (Figure 10A), indicative of an activated HSF1 [12,45]. In
contrast, CpdA treatment for 30min, 1h (Figure S9) and up to 4h
did not result in the aggregation of HSF1 in nuclear stress granules
(Figure 10A). From Western blot analyses it also became clear that
CpdA does not affect HSF1 cellular protein levels (Figure S10A-B).
Moreover, CpdA does not shift the HSF1 band to a higher
molecular weight, whereas heat shock treatment can induce a shift
of HSF1, suggesting intense phosphorylation and thus activation
(Figure S10A) [13,45]. Moreover, when investigating HSF1
recruitment to the proximal HSPA1A gene promoter via ChIP
analysis, we could demonstrate that heat shock induces a
significant increase in HSF1 recruitment at this site (Figure 10B).
In contrast, CpdA did not significantly change HSF1 occupancy at
the HSPA1A promoter (Figure 10B). As expected, the GC DEX
did not affect basal recruitment of HSF1 at the HSPA1A
promoter. The specificity of the HSF1 signal was verified via
analysis of binding to rabbit IgG. Taken together, CpdA does not
stimulate HSF1 transcription factor activity, in contrast to heat
shock treatment.
Discussion
The selective GR modulator CpdA (Figure 1A) is capable of
efficaciously inhibiting NF-kB-driven gene expression while
leaving GRE-regulated promoter activity unaffected (Figure 1)
[5]. CpdA competes with DEX for GR binding, forcing GR into a
monomer formation and evoking GR translocation into the
nucleus in various cell lines [8]. The CpdA-mediated mechanism
repressing NF-kB-driven gene expression depends on the presence
of GR, since CpdA’s anti-inflammatory effect could not be
observed in HEK293T cells devoid of a significant amount of
Figure 6. Compound A does not affect proteasomal degrada-
tion or translation. (A) A549 cells were preinduced with Solv or
MG132 (5mM) for 1.5 h. Subsequently, cells were stimulated with Solv or
CpdA (10mM) for 6h or subjected to the following temperature protocol
: 2 hours at 43uC followed by 2 hours at 37uC (HS+Rec), as indicated.
Total cell protein extracts were subjected to Western blot analysis
detecting inducible Hsp70. Detection of PARP served as a loading
control. The displayed bands were detected from one single
membrane. (B) A549 cells were starved for 48h in 0% DMEM, after
which these cells were treated with solvent for 48h or Compound A
(CpdA) (10mM) for 2h, 6h, 24h or 48h. Total cell protein extracts were
subjected to Western blot analysis detecting b-catenin. Tubulin
detection served as a loading control.
doi:10.1371/journal.pone.0069115.g006
Figure 7. The glucocorticoid receptor interacts with Hsp70 and
Hsp90. HEK293T cells were transiently co-transfected with the MAPPIT
GRa-bait plasmid, the STAT3-responsive rPAP1-luci reporter plasmid
and prey-plasmids as indicated. Empty prey is used as a negative
control. Twenty-four hours after transfection cells were stimulated with
leptin (100ng/ml) and leptin in combination with DEX (1mM) or CpdA
(10mM) for another 24h or were left untreated (NS). Luciferase
measurements were performed in triplicate. Data are expressed as
mean fold induction (ratio stimulated/untreated).
doi:10.1371/journal.pone.0069115.g007
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Figure 8. Compound A increases Hsp70 promoter activity dose-dependently and transiently. (A) L929sA cells, stably transfected with a
mHsp70i-luc reporter gene construct, were left untreated (Untr) or were stimulated with heat shock at 43uC for 2h, followed by a recovery period of
2h at 37uC (HS+Rec). Normalized luciferase levels were presented as relative reporter gene activity with the condition ‘Untr’ set as 1. Statistical analysis
(unpaired t-test) was performed. This figure is representative for 6 independent experiments. (B) L929sA cells, stably transfected with mHsp70i-luc,
were induced for 8h with various concentrations of CpdA, as indicated. All samples were controlled to a similar amount of solvent. This figure is
representative for 4 independent experiments. (C) L929sA cells, stably transfected with mHsp70i-luc, were treated with solvent (Solv) or CpdA (10mM)
for 6h, 24h or 48h. Data were presented as relative reporter gene activity with the Solv condition set as 1. Statistical analysis (ANOVA with Tukey’s
multiple comparison post test) was performed to explore if Solv differs from CpdA treatment for each respective induction time. (D) A549 cells, were
treated with solvent or CpdA 10mM for the indicated time period. Total cellular mRNA was subjected to RT-qPCR detecting gene expression levels for
HSPA1A, normalized using housekeeping 36B4 and b-actin mRNA levels. Four independent experiments with slightly varying time kinetics all show
comparable results. (E) PC-3 cells were starved for 48h in 0% DMEM, after which these cells were left untreated or treated with Compound A (10mM),
as indicated. Purified mRNA was subjected to RT-qPCR detecting HSPA1A gene expression levels and specific results were normalized to
housekeeping controls cyclophilin, GAPDH and 36B4. (B)(D)(E) Solv condition was set as 1 and results recalculated accordingly. Statistical analysis
(ANOVA with Tukey’s multiple comparison post test) was performed to compare with Solv (ns not significant; ** p,0.01; *** p,0.001).
doi:10.1371/journal.pone.0069115.g008
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Figure 9. CpdA stimulation of the Hsp70 gene promoter occurs via a GR-dependent mechanism. (A) A549 cells were transfected with
siControl or siRNA targeting GR (siGR). Total RNA or total protein extracts were prepared 48h post-transfection. In the left panel, purified mRNA was
subjected to RT-qPCR detecting GR gene expression levels, normalized to housekeeping controls cyclophilin and 28S. For the siControl-transfected
sample, signal was set at 100%. Data from SiGR-transfected cells were recalculated accordingly. Statistical analysis (unpaired t-test) was performed to
show significant difference between siControl and siGR conditions (*** p,0.001). In the right panel, total cell lysates were subjected to Western blot
analysis to detect GR protein, with NF-kB p65 as a loading control. (B) In parallel with (A) A549 cells were transfected with siControl or siGR. 41h post
transfection, cells were induced with Solv or CpdA (10mM) for 8h. The derived purified mRNA was subjected to RT-qPCR detecting HSPA1A gene
expression levels and specific results were normalized to housekeeping controls cyclophilin and 28S. The condition Solv (siControl) was set as 1 to
allow ratio comparisons. Statistical analysis (ANOVA with Tukey’s multiple comparison post test) was performed for selected pair wise comparisons
(ns not significant; * p,0.05). This experiment is representative for 2 independent experiments. (C) and (D) A549 cells, serum-starved for48h in 0%
DMEM, were treated with Solv, Dex (1mM), CpdA (10 mM) for 2h, or exposed to a 43uC heat shock (HS) for 1h. Total cell extracts were subjected to a
ChIP assay targeting GR. Ensuing, qPCR signal of immunoprecipitated HSPA1A and GILZ gene promoter fragments is presented relative to input data.
Binding to rabbit IgG represents aspecific binding. Statistical analysis (ANOVA with Tukey’s multiple comparison post test) was performed to show
significant difference with the Solv condition (ns not significant; *** p,0.001). This experiment is representative for 2 independent experiments.
doi:10.1371/journal.pone.0069115.g009
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endogenous GR [5], and was lost in FLS cells in which GR had
been efficiently knocked down [39].
Role of Hsp70 in CpdA’s anti-inflammatory Mechanism
Hsp70 and activated HSF1 are anti-inflammatory mediators
targeting NF-kB in various cell systems [17,18,37,46]. Mechanis-
tically, elevation of the Hsp70 levels targets IKKc, resulting in a
disruption of the IKK complex [18,37]. Although elevated Hsp70
levels can inhibit, but not abolish, IkBa phosphorylation and does
not affect IkBa ubiquitination [18,38], heat shock induction
leading to increased Hsp70 levels impairs IkBa proteasomal
degradation and limits the subsequent NF-kB p65 translocation
[18,37,38]. Additionally, heat shock can elevate IkBa promoter
activity and mRNA stability [47,48]. Furthermore, elevated Hsp70
levels can negatively affect the release of the pro-inflammatory
high mobility group box 1 (HMGB1) [38]. Given the mechanistic
resemblance between heat shock and CpdA, with respect to their
effects on cytokine gene expression, IkBa degradation and NF-kB
p65 nuclear translocation (Figure 2, Figure S2) in various cell
systems [39,40,49,50], we were not surprised to detect that CpdA
can elicit a concentration-dependent, yet transient, rise in Hsp70-
coding mRNA levels and promoter activity (Figure 4, 8, Figure S4)
in human A549 and PC-3 cells and murine L929sA cells. These
findings could be confirmed in human MCF7 breast cancer cells
(Figure S5) and skins of BALB/c mice (Figure 4C), indicating
species-, cell- and tissue independence of this phenomenon.
Knocking down Hsp70 abrogates the ability of CpdA to repress
TNF-stimulated IL8 and IL6 gene expression (Figure 3, Figure
S3). However, in spite of the clear effect of CpdA on Hsp70
promoter activity and gene expression, no CpdA-instigated
elevation in Hsp70 protein was detected (Figure 5B-D, Figure
S7). Experiments with the translational elongation inhibitor CHX
indicate that CpdA’s anti-inflammatory mechanism does not
require de novo protein synthesis (Figure 5A) and a persistent
association was observed between pre-existing Hsp70 and CpdA-
activated GR (Figure 7, Table 1, Table S2). Taken together, these
results most likely point to a role of Hsp70 in the GR chaperone
complex to mediate the ‘reception’ of CpdA by the GR-Hsp70
complex (Figure 7, Table 1, Table S2), additionally supporting the
concept that the CpdA-regulated anti-inflammatory mechanism
acts via GR binding and subsequent modulation of GR-dependent
phenomena.
The underlying reason for the disconcordance between Hsp70
gene expression and Hsp70 protein production following CpdA
treatment is currently unknown. Although secreted Hsp70 has
immunomodulatory effects [51,52,53] we were unable to find
support for a CpdA- or heat shock-induced secreted Hsp70.
Furthermore, we investigated whether a rapid proteasomal
degradation of Hsp70 [54,55] could lie at the basis of the
difference between protein versus mRNA and reporter gene
activity results. As expected, MG132-mediated blocking of
proteasomal degradation could elevate basal Hsp70 protein levels
substantially, either via the inhibition of Hsp70 protein degrada-
tion [54,55] or also via a HSF1-based stimulation of Hsp70 gene
transcription [56,57,58,59]. However, the induction of Hsp70 by
CpdA treatment in the presence of MG132 is not enhanced in
comparison to the natural CpdA-stimulated fold induction of
Hsp70 protein in the absence of MG132 (Figure 6A), indicating
that the minor fold increase is not caused by a rapid turn-over of
CpdA-induced Hsp70 protein. Furthermore, we could show that
CpdA does not enforce a general block on translation as the
translation of luciferase (Figure 8B-C) and galactosidase (Figure
Figure 10. Compound A does not activate HSF1. (A) A549 cells, starved for 48h in Optimem, were treated with solvent (Solv) or CpdA (10mM)
for 4h or heat-shocked (HS) at 43uC for 1h. Via indirect immunofluorescence using an a-HSF1 Ab, endogenous HSF1 was visualized (green) and DAPI
staining indicates the nuclei of the cells (blue). We also present an overlay and in the panel below, we digitally zoom in on one cell. White arrow
heads indicate nuclear stress granules or foci of HSF1. This experiment is representative for 2 independent experiments. (B) A549 cells, starved for 48h
in 0% DMEM, were treated with Solv, CpdA (10mM) or DEX (1mM) for 2h or HS at 43uC for 1h. Total cell extracts were subjected to a ChIP assay
targeting HSF1. Ensuing, qPCR signal of immunoprecipitated HSPA1A gene promoter fragments is presented relative to input data. Binding to rabbit
IgG represents aspecific binding. Statistical analysis (ANOVA with Tukey’s multiple comparison post test) was performed to show significant
difference with the Solv condition (ns not significant; *** p,0.001). This experiment is representative for 2 independent experiments.
doi:10.1371/journal.pone.0069115.g010
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S8B) in various reporter gene assays is not blocked. Moreover, the
protein level of b-catenin, a protein with a short half-life of
approximately 2–3h [41,42,43] shows no decline in response to
CpdA, not even after 48h, in both A549 and PC-3 cells (Figure 6B,
Figure S8A). However, the puzzling matter of a CpdA-induced
rise in HSPA1A mRNA without the expected rise in Hsp70
protein remains. More than one hypothesis can account for this
observation: for example, a sequence-specific inhibition of
translation may occur or, alternatively, CpdA might elevate
Hsp70 targeting miRNAs [60]. These possibilities would require
extensive additional research. The consistent observation that
CpdA can induce Hsp70 mRNA gene expression, without
elevating Hsp70 protein levels makes us wonder what the precise
role of this CpdA-stimulated Hsp70 mRNA might be. It is
tempting to speculate that Hsp70 mRNA could serve as a cofactor,
conform reports on the steroid receptor RNA activator SRA
[61,62,63], which acts as a steroid receptor cofactor. Similar to
Hsp70, some isoforms of SRA do code for a functional protein, i.e.
SRAP. Finally and less exciting, the CpdA-induced production of
Hsp70 mRNA may be an unintentional by-product of CpdA-
modulated mechanisms. Albeit the question remains why the cell
would spend energy on transcribing a mRNA with no further
functional implication. Additional research could shed more light
on this matter.
CpdA-mediated Hsp70 Gene Transcription
Stimulation with CpdA combined with heat shock results in
higher HSPA1A gene expression levels, than in solely heat shock-
or CpdA-induced cells (Figure 4B). This additional Hsp70 mRNA
increase could therefore suggest alternative Hsp70 promoter
activation mechanisms. The latter hypothesis, potentially implying
that heat shock-inducible HSF1 does not act as a mediator of
CpdA-mediated Hsp70 upregulation, is clearly supported by the
following arguments. First, in contrast to heat shock treatment,
CpdA does not enhance HSF1 recruitment to the HSPA1A
promoter (Figure 10B). Second, CpdA does not trigger the
formation of nuclear stress granules of HSF1, which are indicative
for heat shock-induced and activated HSF1 [12,45] (Figure 10A).
In addition, a second mechanistic aspect of the CpdA-mediated
Hsp70 increase, was revealed upon investigating GR dependence.
Our results strongly suggest that the presence of GR is an absolute
requirement for the CpdA-instigated HSPA1A mRNA upregula-
tion (Figure 9B). However, the involvement of GR does not
coincide with a recruitment of GR to the HSPA1A gene promoter,
suggesting that GR might act as a mediator rather than an
effector. Interestingly, it has been described that GCs can repress
heat shock-induced Hsp70 gene expression [64,65], via the
interference of GC-activated GR with the recruitment of the
transcription factor HSF1 to the proximal HSE-elements in the
Hsp70 promoter [65]. These reports provide the context for the
observed DEX-mediated recruitment of GR to the HSPA1A gene
promoter (Figure 9C). Although stimulation of Hsp70 promoter
activity by CpdA is GR-dependent, this mechanism is most likely
not a classical GR dimer-driven, GRE-regulated transactivation as
CpdA does not mediate GRE-regulated transcription, does not
instigate GR dimerization and actively drives GR into a monomer
formation [5,7].
To sum up, CpdA and heat shock use different signalling
pathways to induce Hsp70 gene expression. Whereas heat shock
activates HSF1, which acts as a transcription factor initiating
Hsp70 gene expression, CpdA does not induce HSF1 activation.
Additionally, CpdA necessitates the GR to be able to trigger
Hsp70 gene expression.
In conclusion, in resemblance to the established anti-inflamma-
tory effect of Hsp70 via halting TNF-stimulated IkBa degradation
and NF-kB p65 translocation, we could show that CpdA partially
hampers TNF-stimulated IkBa degradation and NF-kB p65
translocation. Correspondingly, CpdA enhances Hsp70 gene
promoter activities and transcription, yet without producing
additional Hsp70 protein. CpdA’s anti-inflammatory mechanism
does not require new protein synthesis and thus new Hsp70
protein production. Nevertheless, the cellular presence of Hsp70
mRNA and protein, most likely as the GR-interacting chaperone,
remains crucial for CpdA’s ability to repress NF-kB-driven gene
expression. Mechanistically, the selective GR modulator CpdA
enhances Hsp70 promoter activity via a HSF1-independent and
GR-dependent mechanism, whereas heat shock induces a rise in
Hsp70 production via a HSF1-dependent and GR-independent
mechanism. These data further support the hypothesis that CpdA
is a dissociative modulator of GR, utilizing GR to repress pro-
inflammatory promoter activation.
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Supporting Information
Figure S1 Both Compound A and heat shock diminish
IL6 gene expression. (A) A549 cells, starved for 48h, were
pretreated for 1.5h with solvent (Solv), DEX (1mM), CpdA (10mM)
or subjected to heat shock treatment (1h at 43uC and 309 recovery
at 37uC), ensued with TNF (2000IU/ml) for 5.5h. Isolated total
RNA was subjected to RT-qPCR assaying IL6 mRNA levels,
normalized to cyclophilin household gene mRNA levels. The TNF
condition was set at 100 and results were recalculated accordingly.
These results are representative of 2 independent experiments.
Statistical analysis (ANOVA and Tukey multiple comparison post
test) were performed for selected pair-wise comparisons.
(TIF)
Figure S2 Compound A diminishes IkBa degradation
and NF-kB translocation. (A) L929sA cells, starved for 48h,
were pretreated for 2h with solvent (Solv), DEX (1mM) or CpdA
(10mM), after which TNF (2000IU/ml) was added as indicated.
Western blot analysis of total cells lysates detects IkBa protein,
with NF-kB p65 as loading control. This figure is representative
for 2 independent experiments. (B) L929sA cells, starved for 48h in
Optimem, were pretreated for 2h with Solvent or CpdA (10mM).
Subsequently, TNF (2000IU/ml) was added for 309, where
indicated. After washing, fixation, and permeabilization, indirect
immunofluorescence detects endogenous NF-kB p65. DAPI
staining indicates the nuclei. Additionally, we present overlays.
(TIF)
Figure S3 Hsp70 is required to allow the anti-inflam-
matory activity of Compound A. A549 cells were transfected
with siControl or siRNA targeting HSPA1A and HSPA1B
(siHsp70). 41h post transfection, cells were pretreated with Solv
or CpdA (10mM) for 2h, after which ensued a 6h TNF (2000IU/
ml) treatment. Total RNA extracts were prepared. Purified
mRNA was subjected to RT-qPCR detecting IL6 gene expression
levels and specific results were normalized to housekeeping
controls cyclophilin and 28S. The condition Solv (siControl) was
set as 1 to allow ratio comparisons. Statistical analysis (ANOVA
with Tukey’s multiple comparison post test) was performed to
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show significant difference for selected pair wise comparisons (ns
not significant; ** p,0.01).
(TIF)
Figure S4 Compound A augments Hsp70 gene expres-
sion. A549 cells, were treated with solvent or CpdA 10mM for the
indicated time period. Total cellular mRNA was subjected to RT-
qPCR detecting gene expression levels for HSPA2 or HSPA6 (as
indicated), normalized using housekeeping 36B4 and b-actin
mRNA levels. The Solv condition was set as 1 and results
recalculated accordingly. Statistical analysis (ANOVA with
Tukey’s multiple comparison post test) was performed to compare
with Solv (ns not significant; ** p,0.01). Three independent
experiments with slightly varying time kinetics all show compa-
rable results. (B) MCF-7 breast cancer cells
(TIF)
Figure S5 CpdA can elevate Hsp70 gene expression
levels in MCF7 cells. (A) MCF7 cells were pretreated with
solvent or CpdA (10mM) for 8 h. Total RNA was reverse
transcribed and HSPA1A and housekeeping GAPDH mRNA
levels were determined via semi-quantitative PCR visualized on a
2% agarose gels. The displayed bands were detected from one
single gel. (B) MCF7 cells were assayed via the ’GEarray Q series
Analysis with Human Stress and Toxicity pathway’ (SABios-
ciences). Cells were treated with solvent or CpdA (10 mM) for 8h.
Total RNA was isolated and reverse transcribed to hybridize
labeled cDNA to Human Stress and Toxicity GEA array
membranes. Results, visualized via Phospho-Imager, were quan-
tified and controlled for by housekeeping genes. Effects of CpdA
are presented as ’fold induction’.
(TIF)
Figure S6 Control of CHX functionality. A549 cells,
starved for 48h, were left untreated or were treated for 7h with
cycloheximide (CHX) (20mg/ml). Total cell protein extracts were
subjected to Western blot analysis detecting b-catenin and an
aspecific band serves as a loading control.
(TIF)
Figure S7 CpdA does not elevate the Hsp70 protein level
in L929sA cells. L929sA cells were treated with solvent or CpdA
(10mM) for 4h,8h or 24h or heat-shocked at 43uC for 2h, after
which cells were left to recover at 37uC for 2h (HS+Rec). Total cell
protein lysates were analyzed via Hsp70 ELISA. Statistical analysis
(ANOVA with Tukey’s multiple comparison post test) was
performed for selected pair-wise comparisons (ns not significant;
**p,0.01). This figure represents averaged data of 2 independent
experiments.
(TIF)
Figure S8 Compound A does not block translation. (A)
PC-3 cells were starved for 48h in 0% DMEM, after which these
cells were treated with solvent for 48h or Compound A (CpdA)
(10mM) for 2h, 6h, 24h or 48h. Total cell protein extracts were
subjected to Western blot analysis detecting b-catenin. Tubulin
detection served as a loading control. (B) L929sA cells, stably
transfected with p(IL6kB)350hu.IL6P-luc+, were left untreated
(NI), or were treated with solvent (Solv), or CpdA (0.1mM, 1mM or
10mM) for 8h. The relative activity of the constitutively expressed
galactosidase (b-gal) controls were presented as relative reporter
gene activity with the condition Solv set at 100. All other
conditions were recalculated accordingly. Statistical analysis
(ANOVA with Tukey’s multiple comparison post test) was
performed (ns not significant).
(TIF)
Figure S9 Heat shock stimulates HSF1 heat shock
granules, but CpdA does not. A549 cells, starved for 48h in
Optimem, were treated with solvent (Solv) for 60 minutes or CpdA
(10mM) for 30 or 60 minutes. Alternatively, cells were heat-
shocked (HS) at 43uC for 30 minutes. Via indirect immunofluo-
rescence using an a-HSF1 Ab, endogenous HSF1 was visualized
(green) and DAPI staining indicates the nuclei of the cells (blue).
We also present an overlay and in the below panel, we digitally
zoom in on one cell. White arrow heads indicate nuclear stress
granules or foci of HSF1. This experiment is representative for 2
independent experiments.
(TIF)
Figure S10 CpdA does not augment the HSF1 level, nor
does it shift the band hight. (A) A549 cells were treated with
Solv, CpdA (10mM) or DEX (1mM) for 2, 4, 6 or 24 hours.
Alternatively, cells were heat-shocked at 43uC for 2h, after which
cells were left to recover at 37uC for 2h (HS+Rec). Total cell
protein extracts were subjected to Western blot analysis detecting
HSF1, with NF-kB p65 as a loading control. This image is
representative for 2 independent experiments. (B) shows the
averaged band densitometric analysis (ImageJ) of 2 independent
HSF1 Western blot analyses. Specific HSF1 signal was corrected
for sample loading. Solv was set as 1 to allow ratio comparisons.
Statistical analysis (ANOVA with Tukey’s multiple comparison
post test) was performed for selected pair wise comparisons (ns not
significant).
(TIF)
Table S1 Detailed siRNA information (Dharmacon,
Thermo Fischer).
(DOCX)
Table S2 List of identified heat shock proteins and their
corresponding peptides. HEK293T cells were transfected
with Flag-hGRa via calcium phosphate and following stimulation
with either solvent (NI) or 10mM CpdA (CpdA), immunoprecip-
itated using Flag beads (plasmid and methodology described in [7].
Two identical set-ups were done in parallel, yet, using two
different elution methods, via NH4OH, as indicated, or via the
Flag peptide (FLAG, 100mg/ml). The identified heat shock
proteins are listed and, per protein, the corresponding peptides
(at 99% confidence settings) are shown (note that Mox indicates
methionine-sulfoxide (oxidation) and Q,Pyr.indicates N-termi-
nal pyroglutamic acid modification). The number of MS/MS
spectra recorded per identified peptide is indicated.
(DOCX)
Materials andMethods S1 All materials and methods, as
described in the manuscript are also valid for the
supporting information figures S1-S10 and tables S1
and S2. Additional materials en methods to understand the
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